Acetaminophen
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Acetaminophen
UNSPSC Description:
Acetaminophen (Paracetamol) is a selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 25.8 μM; is a widely used antipyretic and analgesic agent.[1][2][3]. Acetaminophen is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor[4]. Acetaminophen induces ferroptosis and leads to acute liver injury in mice model[5].Target Antigen:
Bacterial; COX; Endogenous Metabolite; Ferroptosis; Histone Acetyltransferase; ParasiteType:
Reference compoundRelated Pathways:
Anti-infection;Apoptosis;Epigenetics;Immunology/Inflammation;Metabolic Enzyme/ProteaseApplications:
COVID-19-immunoregulationField of Research:
Inflammation/Immunology; CancerAssay Protocol:
https://www.medchemexpress.com/acetaminophen.htmlPurity:
99.98Solubility:
DMSO : 250 mg/mL (ultrasonic)|H2O : 10 mg/mL (ultrasonic)Smiles:
O=C(C)NC1=CC=C(O)C=C1Molecular Weight:
151.16References & Citations:
[1]Hinz, B, et al. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J, 2008. 22(2): p. 383-90.|[2]Miroslav Dinić, et al. Lactobacillus fermentum Postbiotic-induced Autophagy as Potential Approach for Treatment ofAcetaminophen Hepatotoxicity. Front Microbiol. 2017 Apr 6;8:594.|[3]Uchida NS, et al. Hepatoprotective Effect of Citral on Acetaminophen-Induced Liver Toxicity in Mice. Evid Based Complement Alternat Med. 2017;2017:1796209.|[4]Rothen JP, et al. Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo. Pharmacogenetics. 1998 Dec;8(6):553-9.|[5]An Y, et al., Abietic acid inhibits acetaminophen-induced liver injury by alleviating inflammation and ferroptosis through regulating Nrf2/HO-1 axis. Int Immunopharmacol. 2023 May;118:110029.Shipping Conditions:
Room TemperatureStorage Conditions:
Store at room temperature 3 yearsClinical Information:
LaunchedCAS Number:
103-90-2
